Vera Therapeutics Stock Price Prediction
| VERA Stock | USD 46.92 0.59 1.24% |
Oversold Vs Overbought
56
Oversold | Overbought |
EPS Estimate Next Quarter (0.69) | EPS Estimate Current Year (2.76) | EPS Estimate Next Year (2.77) | Wall Street Target Price 64.5833 | EPS Estimate Current Quarter (0.66) |
Using Vera Therapeutics hype-based prediction, you can estimate the value of Vera Therapeutics from the perspective of Vera Therapeutics response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards Vera Therapeutics using Vera Therapeutics' stock options and short interest. It helps to benchmark the overall future attitude of investors towards Vera using crowd psychology based on the activity and movement of Vera Therapeutics' stock price.
Vera Therapeutics Short Interest
A significant increase or decrease in Vera Therapeutics' short interest from the previous month could be a good indicator of investor sentiment towards Vera. Short interest can provide insight into the potential direction of Vera Therapeutics stock and how bullish or bearish investors feel about the market overall.
200 Day MA 40.8871 | Short Percent 0.1373 | Short Ratio 6.81 | Shares Short Prior Month 6.4 M | 50 Day MA 44.5796 |
Vera Therapeutics Hype to Price Pattern
Investor biases related to Vera Therapeutics' public news can be used to forecast risks associated with an investment in Vera. The trend in average sentiment can be used to explain how an investor holding Vera can time the market purely based on public headlines and social activities around Vera Therapeutics. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Some investors profit by finding stocks that are overvalued or undervalued based on market sentiment. The correlation of Vera Therapeutics' market sentiment to its price can help taders to make decisions based on the overall investors consensus about Vera Therapeutics.
Vera Therapeutics Implied Volatility | 0.59 |
Vera Therapeutics' implied volatility exposes the market's sentiment of Vera Therapeutics stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Vera Therapeutics' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Vera Therapeutics stock will not fluctuate a lot when Vera Therapeutics' options are near their expiration.
The fear of missing out, i.e., FOMO, can cause potential investors in Vera Therapeutics to buy its stock at a price that has no basis in reality. In that case, they are not buying Vera because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Vera Therapeutics after-hype prediction price | USD 46.94 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Prediction based on Rule 16 of the current Vera contract
Based on the Rule 16, the options market is currently suggesting that Vera Therapeutics will have an average daily up or down price movement of about 0.0369% per day over the life of the 2024-12-20 option contract. With Vera Therapeutics trading at USD 46.92, that is roughly USD 0.0173 . If you think that the market is fully incorporating Vera Therapeutics' daily price movement you should consider acquiring Vera Therapeutics options at the current volatility level of 0.59%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Vera |
Vera Therapeutics After-Hype Price Prediction Density Analysis
As far as predicting the price of Vera Therapeutics at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Vera Therapeutics or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Vera Therapeutics, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Vera Therapeutics Estimiated After-Hype Price Volatility
In the context of predicting Vera Therapeutics' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Vera Therapeutics' historical news coverage. Vera Therapeutics' after-hype downside and upside margins for the prediction period are 43.22 and 50.66, respectively. We have considered Vera Therapeutics' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Vera Therapeutics is not too volatile at this time. Analysis and calculation of next after-hype price of Vera Therapeutics is based on 3 months time horizon.
Vera Therapeutics Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Vera Therapeutics is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Vera Therapeutics backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Vera Therapeutics, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.50 | 3.72 | 0.02 | 0.01 | 10 Events / Month | 17 Events / Month | In about 10 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
46.92 | 46.94 | 0.04 |
|
Vera Therapeutics Hype Timeline
Vera Therapeutics is at this time traded for 46.92. The entity has historical hype elasticity of 0.02, and average elasticity to hype of competition of -0.01. Vera is projected to increase in value after the next headline, with the price projected to jump to 46.94 or above. The average volatility of media hype impact on the company the price is over 100%. The price jump on the next news is projected to be 0.04%, whereas the daily expected return is at this time at 0.5%. The volatility of related hype on Vera Therapeutics is about 14501.69%, with the expected price after the next announcement by competition of 46.91. The company reported the previous year's revenue of 1.86 M. Net Loss for the year was (95.99 M) with profit before overhead, payroll, taxes, and interest of 0. Given the investment horizon of 90 days the next projected press release will be in about 10 days. Check out Vera Therapeutics Basic Forecasting Models to cross-verify your projections.Vera Therapeutics Related Hype Analysis
Having access to credible news sources related to Vera Therapeutics' direct competition is more important than ever and may enhance your ability to predict Vera Therapeutics' future price movements. Getting to know how Vera Therapeutics' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Vera Therapeutics may potentially react to the hype associated with one of its peers.
Vera Therapeutics Additional Predictive Modules
Most predictive techniques to examine Vera price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Vera using various technical indicators. When you analyze Vera charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Vera Therapeutics Predictive Indicators
The successful prediction of Vera Therapeutics stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Vera Therapeutics, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Vera Therapeutics based on analysis of Vera Therapeutics hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Vera Therapeutics's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Vera Therapeutics's related companies. | 2023 | 2024 (projected) | Interest Debt Per Share | 1.22 | 1.29 | Revenue Per Share | 0.0392 | 0.0349 |
Story Coverage note for Vera Therapeutics
The number of cover stories for Vera Therapeutics depends on current market conditions and Vera Therapeutics' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Vera Therapeutics is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Vera Therapeutics' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Vera Therapeutics Short Properties
Vera Therapeutics' future price predictability will typically decrease when Vera Therapeutics' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Vera Therapeutics often depends not only on the future outlook of the potential Vera Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Vera Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 42.7 M | |
| Cash And Short Term Investments | 160.7 M |
Complementary Tools for Vera Stock analysis
When running Vera Therapeutics' price analysis, check to measure Vera Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vera Therapeutics is operating at the current time. Most of Vera Therapeutics' value examination focuses on studying past and present price action to predict the probability of Vera Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vera Therapeutics' price. Additionally, you may evaluate how the addition of Vera Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Transaction History View history of all your transactions and understand their impact on performance | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities |